Safety Study of Use of Autologous Bone Marrow Derived Stem Cell in Treatment of Age Related Macular Degeneration

NCT02016508 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Age Related Macular Degeneration

Interventions

DRUG: autologous bone marrow derived stem cells

Sponsor

Al-Azhar University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]